Company Overview of Ardent Pharmaceuticals, Inc.
Ardent Pharmaceuticals, Inc., a biotechnology company, engages in the discovery, development, and commercialization of delta receptor compounds. It develops a range of drugs for use in moderate to severe pain, urinary incontinence, premature ejaculation, depression, cardioprotection, glaucoma, neuroprotection, immunomodulation, and drug abuse. The company’s DPI-3290 IV formulation is used for acute pain. Ardent Pharmaceuticals, Inc. was formerly known as Delta Pharmaceuticals, Inc. The company is based in Durham, North Carolina. As of 12/20/2004, Ardent Pharmaceuticals, Inc. is a subsidiary of Enhance Biotech, Inc.
631 United Drive
Durham, NC 27713
Key Executives for Ardent Pharmaceuticals, Inc.
Similar Private Companies By Industry
|E. R. Squibb & Sons Inter-American Corporation||United States|
|Karos Pharmaceuticals, Inc.||United States|
|Cherokee Pharma, LLC||United States|
|Catena Pharmaceuticals, Inc.||United States|
|Roxlor, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Ardent Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.